Articles tagged with Antiinflammatory Drugs
Researchers found that children with asthma often miss their daily medication due to barriers such as forgetfulness and running out of medication. The study suggests that improving communication among patients, families, and pediatric clinicians is crucial to ensure consistent use of daily anti-inflammatory medication.
The study reveals that the glucocorticoid receptor (GR) can directly bind to DNA at NF-kappaB sites, one at a time, turning down inflammation genes. This finding could lead to reinterpretation of previous studies and potential development of targeted drugs.
A recent study published in British Journal of Clinical Pharmacology found a significant link between nonsteroidal anti-inflammatory drugs (NSAIDs) and an increased risk of atrial fibrillation. The research highlights the importance of closely monitoring NSAID use for heart health, particularly among high-risk individuals.
A Taiwanese database study of 55,629 patients with hypertension found no significant difference in cardiovascular risk between cyclooxygenase-2 enzyme selective NSAIDs and nonselective NSAIDs. Most commonly used NSAIDs have similar cardiovascular safety profiles under low-to-moderate daily doses and short-term treatment periods.
Researchers found that 15% of adult ibuprofen users exceed the maximum recommended dose in a one-week period. Those who do tend to have medical factors such as chronic pain and poor physical state, attitudes conducive to ignoring label recommendations, and poor knowledge of those recommendations.
Researchers synthesized 30 flavanone derivatives to target NF-kappaB, identifying compounds with potent anti-inflammatory and cytotoxic activities against various cancer cell lines. The top-ranked compounds exhibited improved pharmacological profiles through conjugation of two pharmacophores.
A recent analysis revealed that proprietary Chinese medicines (pCMs) are frequently adulterated with undeclared agents, posing serious health hazards. The study identified 404 cases involving 487 adulterated pCMs or health products, with 65% of patients experiencing adverse effects.
Researchers found that testosterone reduces the effectiveness of anti-inflammatory drugs in men, increasing prostaglandins and promoting inflammatory reactions. This discovery supports the need for gender-specific medicine, suggesting that treatment may require separate 'his' and 'hers' medicine cabinets.
A nationwide Swedish study linked alendronate treatment to a lower risk of hip fractures in elderly patients using medium to high doses of anti-inflammatory medication. The research also found that longer treatment duration was associated with a greater reduction in fracture risk.
A study found that commonly prescribed NSAIDs increase the risk of heart attacks, with a 20-50% increased risk compared to non-users. The risk is highest with higher doses and in the first month of use.
The American College of Physicians recommends treating acute and subacute low back pain with non-pharmaceutical therapies like heat, massage, and spinal manipulation. For chronic low back pain, exercise, multidisciplinary rehabilitation, and acupuncture are shown to improve symptoms.
Researchers at the University of Manchester have discovered a potential new drug that reduces brain cell death and promotes neurogenesis after a stroke. The drug, interleukin-1 receptor antagonist (IL-1Ra), is already licensed for use in humans for other conditions and has shown promise in early clinical trials.
Studies suggest inflammatory cytokines are associated with increased rates of depression and psychosis. Anti-cytokine treatment has been shown to reduce symptoms of depression in clinical trials, regardless of physical illness improvement.
Researchers found that anti-cytokine drugs showed significant antidepressant effects compared to placebo in clinical trials. The study suggests inflammation plays a role in depression and that these drugs may offer hope for patients who don't respond to current treatments.
Research highlights ethosomes as a promising nanocarrier system for efficient transdermal drug delivery. The article presents various preclinical and clinical studies showcasing the enhanced absorption and bioavailability of antimicrobials, anti-inflammatory drugs, and CNS acting compounds upon loading into ethosomes.
Researchers will develop new therapies to protect brain and organs from secondary damage after traumatic events. A promising class of anti-inflammatory and cytoprotective drugs called tetracyclines show promise in preventing such damage.
Researchers have successfully treated an experimental model of Alzheimer's disease with mefenamic acid, a commonly used anti-inflammatory drug. The study found complete reversal of memory loss and brain inflammation in mice, paving the way for human trials.
Researchers explore Fasudil as a therapeutic option for Alzheimer's disease, finding it reduces Aβ deposition, Tau phosphorylation, and inflammation. The treatment also improves learning and memory deficits in APP/PS1 transgenic mice.
Researchers found that administering a small dose of the anti-inflammatory drug dexamethasone before surgery and avoiding profound anesthesia can help reduce the incidence of POCD. After six months, pre-operative cognitive status was restored in all patients in the study.
Researchers found that mosquito bites enhance the replication of viral infections like Zika and dengue by triggering an inflammatory response in the body. Anti-inflammatory medications may be effective in stopping this process and preventing severe illness.
Scientists at Technical University of Munich have developed a biochemical strategy to synthesize natural and artificial medical agents using templated enzyme design. They successfully produced precursor of Taxol, anti-inflammatory substances, and omega-3 fatty acids, showcasing the potential of their new molecular toolkit.
Researchers have developed a new method for synthesizing phenyl-substituted 3,6-Dihydro-2H-pyran derivatives with high enantiomeric purity. The results showcase the potential of this approach for producing pharmaceuticals and other valuable compounds.
A major study has shown that intervening in primary care health practices can significantly reduce rates of high-risk prescribing of drugs. The study found a 37% reduction in high-risk prescribing and associated reductions in emergency hospital admissions for related complications.
A recent study suggests that immunotherapy can improve cognitive ability in patients with schizophrenia by suppressing inflammation. The study found significant improvements in cognitive function after just two doses of an immune-suppressing drug, tocilizumab.
Researchers are exploring the anti-inflammatory drug's ability to improve cognition in patients with stable schizophrenia or schizoaffective disorder. The study aims to enroll 30 patients and examine the effects of siltuximab on cognitive impairment, which is a significant unmet need in treating schizophrenia.
Scientists have developed a new treatment strategy that restores a brain region controlling emotions and reduces chronic pain behavior in animal models. The combined drugs target brain circuits and eliminate chronic pain when administered together shortly after an injury.
Researchers at WSU will collaborate with Botanisol to study TAI-LCx, a newly identified active component of turmeric, and develop better means to isolate it. Early research showed TAI-LCx to be effective at reducing inflammation using biologic pathways different from NSAIDs.
Researchers at Georgia State University develop an oral drug using microparticles and natural herbal molecules to target colon inflammation in ulcerative colitis. The curcumin-loaded microparticles show potential as a scalable drug carrier for efficient clinical treatment of this chronic gastrointestinal disease.
The review highlights the major achievements in liposome technology, including modern synthesis methods, drug delivery systems, and their use in disease diagnosis. Liposomes are being explored as a potential solution to improve treatment outcomes and reduce side effects for various diseases, including cancer and inflammatory conditions.
Researchers have developed a dynamic 'smart' drug that targets inflammation in a site-specific manner, reducing side effects. The new anti-inflammatory molecule reduces local inflammation while avoiding normal inflammatory processes, potentially improving treatment outcomes for immunosuppressed patients and those undergoing chemotherapy.
Researchers found that only 34% of fixed-dose drug combinations (FDCs) in India received central regulatory approval. FDCs containing anti-depressant/benzodiazepine drugs were sold without CDSCO approval in over two-thirds of cases, highlighting the need for stricter regulations and monitoring.
A new study published in the American Journal of Pathology shows that inflammation plays a causal role in Lyme disease's neurologic changes, and anti-inflammatory drugs like dexamethasone may prevent these effects. Researchers found that dexamethasone prevented many neuropathologic effects, while meloxicam was generally ineffective.
Researchers found a consistent dose-response relationship between paracetamol and adverse events, including mortality, cardiovascular, gastrointestinal, and renal problems. This suggests that clinicians should reevaluate the drug's effectiveness and tolerability for certain conditions, particularly when analgesic benefit is uncertain.
A recent study found that delays in the withdrawal of drugs from the market due to reported deaths could have been reduced if there were more efficient reporting and regulatory processes. The researchers identified 95 drugs that were withdrawn due to deaths, with most being used to treat neurological or psychiatric disorders.
Phospholipase A2 (PLA2) enzymes play a role in inflammatory diseases. Researchers created 3D models that show how PLA2 enzymes extract substrates from cell membranes, triggering inflammation. These models could help design and develop specific PLA2 inhibitor drugs.
A study published in JAMA Surgery found that nonsteroidal anti-inflammatory drug (NSAID) use is associated with a higher risk of anastomotic leaks after nonelective colorectal procedures. The study included over 13,000 patients and showed a 24% increased risk for anastomotic leak among those who received NSAIDs.
A study published in Neurology found that people taking certain COX-2 inhibitors were 19% more likely to die after a stroke. New users of older COX-2 drugs, such as etodolac, were 42% more likely to die from stroke.
A large-scale study has found that combining anti-inflammatory medications with antidepressants can have a positive impact on treating depression. The analysis confirms a correlation between inflammation and depression, suggesting that personalized treatment options may be possible.
A comprehensive meta-analysis of robust studies shows that anti-inflammatory medicines, such as aspirin, can add to the effective treatment of schizophrenia. The study suggests that selecting specific anti-inflammatory agents could lead to improved patient responses and new treatment approaches.
A new study published in Rheumatology found that NSAID users have a higher risk of developing venous thromboembolism, which includes deep vein thrombosis and pulmonary embolism. The study's lead author notes that physicians should be cautious when prescribing NSAIDs to patients already at high risk of VTE.
A study led by Queen's University professor Robert Campbell revealed that using anti-inflammatory medicines after common eye surgery isn't helpful or necessary. The research found that steroids and nonsteroidal anti-inflammatory drugs do not affect the ability of laser treatment to lower eye pressure.
A new study has failed to identify a medical treatment for post-operative pericardial effusion (POPE), a potentially serious condition that can lead to cardiac tamponade. The POPE-2 study showed that colchicine had no effect in reducing the volume of fluid around the heart or preventing the risk of cardiac tamponade.
Researchers at Emory University School of Medicine found that XPro1595 can protect vulnerable neurons and reduce motor deficits in a rat model of Parkinson's disease. The drug targets tumor necrosis factor, a critical inflammatory signaling molecule, and showed benefits when administered by subcutaneous injection.
Researchers found that triple-negative breast cancer tumors rely on an antiviral pathway driving inflammation, which can be treated with JAK inhibitors. Patients missing both p53 and ARF genes may benefit from these anti-inflammatory drugs.
Recent research from BUSM sheds light on the regulatory strategies controlling PPARgamma activity in cells, offering potential avenues for developing effective treatments. By targeting specific subsets of PPARgamma target genes, researchers aim to improve insulin sensitivity and combat type 2 diabetes.
Researchers at Karolinska Institutet have successfully produced a molecule that blocks LTA4 hydrolase from producing LTB4, while maintaining the inactivation of Pro-Gly-Pro. This could lead to new hopes for treating chronic obstructive pulmonary disease (COPD) and various types of inflammatory skin diseases.
Scientists created nanoparticles that selectively bind to abnormal immune cells causing inflammation, allowing anti-inflammatory drugs to reach them while leaving healthy ones untouched. This targeted approach shows promise for treating inflammatory diseases with fewer side effects.
Researchers used induced pluripotent stem cells to test NSAIDs on human neurons, finding they failed to respond despite initial success in cell and animal models. The study highlights the importance of testing compounds directly in authentic human cells for more reliable drug development approaches.
Researchers found that oxygen levels alter the effectiveness of anti-inflammatory glucocorticoid drugs in neutrophil lifespans. This discovery may help tailor anti-inflammatory agents to specific diseases, improving treatment outcomes for patients with severe asthma, COPD, and other inflammatory conditions.
Researchers developed new methods for synthesizing coumarin-based drugs, which showed promise as anti-inflammatory agents. The study revealed one of the pathways in which coumarins act, and understanding this pathway may help develop future treatments for chronic inflammation diseases.
Researchers have developed a squishy gel that releases an anti-inflammatory drug when compressed, like a painful knee joint. The new material could deliver medications on-demand to alleviate osteoarthritis symptoms.
A study published in Experimental Physiology found that paracetamol can improve exercise endurance in the heat by reducing body temperature. This improvement allows individuals to exercise for longer periods without overheating. The researchers hope to investigate the specific mechanisms by which paracetamol achieves this effect.
A new study reveals that one in eight high-risk patients using over-the-counter NSAIDs take the medication despite knowing the risks. The most common reasons for use were musculoskeletal complaints, with 67% citing this as a reason.
Researchers discovered that naproxen blocks the RNA binding groove of the nucleoprotein, preventing formation of the ribonucleoprotein complex. This finding suggests that naproxen could be an effective treatment against influenza A virus.
A study finds diclofenac is the most commonly used NSAID in 15 countries and is included on essential medicines lists of 74 low- to high-income countries. Despite its cardiovascular risks, researchers call for diclofenac to be removed from national lists and have its global marketing authorisations revoked.
A study found that taking a triple combination of blood pressure drugs and common painkillers increases the risk of serious kidney problems, especially at the start of treatment. Patients taking this combination are 31% more likely to develop kidney injury.
Scientists at the University of Nottingham have discovered that cordycepin, a compound found in rare parasitic fungi, has potential as an anti-inflammatory drug. The study shows that cordycepin reduces inflammatory gene products in airway smooth muscle cells, making it a potential treatment for asthma and other inflammatory conditions.
University of Utah medical researchers have identified a new pathway to block inflammation while minimizing the risk of infection, which could lead to more effective treatments for conditions like arthritis, diabetes, and traumatic brain injury. The discovery has vast potential for developing safer anti-inflammatory medicines.
A research team at VIB has identified a new anti-inflammatory mechanism of the protein A20, which can help treat autoimmune diseases like Rheumatoid Arthritis. By understanding how A20 interacts with signaling pathways, scientists can develop new therapies to combat inflammation and disrupt the immune system's attack on its own tissues.
Researchers have shown that a new class of anti-inflammatory agents, called IDR peptides, could increase survival from severe clinical malaria when used in combination with antimalarial drugs. In mouse models infected with the Plasmodium berghei parasite, these treatments prevented inflammation and improved survival.